(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘Novartis
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
January 04, 2021
Our Take: Pharma companies sign spate of deals before year-end
Read More
August 12, 2019
Our Take: FDA threatens legal action against Novartis over faulty data used in application for $2.1 million gene therapy
Read More
August 12, 2019
Episode 65: Our Take, August 12, 2019
Read More
June 10, 2019
Episode 53: Our Take, June 10, 2019
Read More
June 03, 2019
Our Take: Novartis sets $2.1M price for spinal muscular atrophy gene therapy, watchdog agrees
Read More
June 03, 2019
Episode 52: Our Take, June 3, 2019
Read More
May 23, 2019
Episode 50: Our Take May–Part 2
Read More
May 20, 2019
Our Take: States accuse Teva, other drugmakers, of price fixing
Read More
April 18, 2019
Episode 45: Our Take April–Part 1
Read More
April 08, 2019
Our Take: Memorial Sloan Kettering: Profits over people?
Read More
October 22, 2018
Our Take: CMS will require drugmakers to list prices in ads
Read More
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
First name
*
Last name
*
Email
*
Company
*
Job Title
*
Thank you for signing up! Check your inbox or spam folder to confirm your subscription.
share
Consulting
Insights
Podcast
DVI
About
Contact Us
